Skip to main content
RTW Biotech Opportunities Ltd logo

RTW Biotech Opportunities Ltd — Investor Relations & Filings

Ticker · RTW ISIN · GG00BKTRRM22 LEI · 549300Q7EXQQH6KF7Z84 IL Financial and insurance activities
Open in API
Filings indexed 543 across all filing types
Latest filing 2026-05-20 AGM Information
Country GG Guernsey
Listing IL RTW

About RTW Biotech Opportunities Ltd

https://www.rtwfunds.com/rtw-biotech-op…

RTW Biotech Opportunities Ltd is an investment fund that focuses on identifying and investing in transformative assets with high growth potential across the global life sciences sector. The company's portfolio is primarily composed of biotechnology and medical technology companies. Managed by RTW Investments, LP, a specialized life sciences investment firm, the fund leverages deep scientific expertise to support companies throughout their entire lifecycle, from early-stage private ventures to publicly traded entities. The investment strategy aims to provide capital and strategic support to advance the development of innovative therapies and technologies.

Recent filings

Filing Released Lang Actions
Publication of Circular and notice of General Meeting
AGM Information Classification · 90% confidence The document is a Notice of Annual General Meeting, detailing the date, proxy voting instructions, resolutions to be considered, and explanatory notes but does not contain actual financial statements or earnings data. It is an AGM notice sent to shareholders to inform them of and solicit votes for the upcoming meeting. This falls under AGM Information (materials shared in connection with the AGM).
2026-05-20 English
Notice of AGM
Proxy Solicitation & Information Statement Classification · 86% confidence The document is an RNS announcement advising shareholders of the dispatch and availability of the Notice of Annual General Meeting, including proxy voting instructions. It does not contain meeting materials or minutes, nor is it a full financial report. Instead it provides materials and instructions to solicit shareholder votes. This aligns with the definition for Proxy Solicitation & Information Statement (PSI).
2026-05-20 English
Monthly Valuation Update and Factsheet
Net Asset Value Classification · 92% confidence The document is an RNS announcement by RTW Biotech Opportunities Ltd providing its unaudited net asset value per share as at 30 April 2026, performance commentary, top positions, sector and portfolio updates. This is a periodic fund NAV update and mini-factsheet for an investment fund rather than an AGM, earnings release, management report or other corporate filing. It includes substantive NAV data, not merely a publication notice. Therefore, it falls under the Net Asset Value update category.
2026-05-14 English
Transaction in Own Shares
Transaction in Own Shares Classification · 92% confidence The document is an RNS announcement by RTW Biotech Opportunities Ltd detailing its buyback of 100,000 ordinary shares and the resulting treasury holdings and voting rights. It clearly fits the category for company share repurchases (“Transaction in Own Shares”).
2026-05-12 English
Additional investment in Windward Bio
Capital/Financing Update Classification · 95% confidence The document is an announcement from RTW Biotech Opportunities Ltd dated 8 May 2026 about an additional investment in Windward Bio, detailing a $165 million crossover financing round and the company's participation in it. It includes information about the investment, the clinical program, and the company's NAV exposure to Windward Bio. The document is relatively short (6450 characters) and does not contain financial statements, detailed financial analysis, or comprehensive report data. It is an update on a financing event related to the company's portfolio investments. The content fits the category of Capital/Financing Update (CAP) as it relates to fundraising and financing activities. It is not an annual or interim report, earnings release, or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2026-05-08 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a TR-1 form notification of major holdings, indicating a change in significant share ownership levels for RTW Biotech Opportunities Ltd. It details the percentage of voting rights held by Bluestem Asset Management, LLC and related entities, including dates and previous notifications. This type of document is a notification of changes in significant share ownership levels, which fits the definition of Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or any other type of report but a regulatory filing specifically about shareholding thresholds.
2026-05-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.